Health ❯ Healthcare ❯ Pharmaceuticals ❯ Medications

GLP-1 Drugs

Yahoo Finance Highlights Merck and Bristol Myers as Value Plays Outside the GLP-1 Surge

Eli Lilly trades near a 50 P/E with its two GLP-1 drugs already supplying more than half of revenue.

White House Clinches GLP-1 Price Deal as Lilly Sets Zepbound and Pill Pricing

UK Regulator Probes Pancreatitis Cases Tied to GLP-1 Weight-Loss Therapies